INIS
diseases
100%
vitamin k
100%
risks
100%
proteins
85%
matrices
62%
patients
53%
infants
50%
coronaviruses
50%
distribution
50%
molecules
50%
neutrophils
50%
muscles
50%
lymphocytes
50%
blood cells
50%
prophylaxis
50%
width
50%
inhibition
50%
birth
50%
kidneys
50%
cardiovascular diseases
38%
liver
28%
vitamins
25%
c-reactive protein
20%
blood pressure
20%
comparative evaluations
17%
fibers
16%
ligands
16%
in vitro
16%
enzymes
16%
humans
14%
Keyphrases
Vascular Calcification
70%
Severe Coronavirus Disease 2019
50%
Red Cell Distribution Width
50%
Small Molecule Inhibitors
50%
At Birth
50%
High Risk
50%
Extracellular Vesicles
50%
Vascular Smooth muscle Cells
50%
Breast Milk
50%
Vitamin K
50%
Neutrophil-to-lymphocyte Ratio
50%
Chronic Kidney Disease
50%
Vitamin K Status
50%
Neutral Sphingomyelinase
50%
Vitamin K Deficiency
50%
Modifiable Risk Factors
50%
NSMase2
50%
Cardiovascular Markers
50%
Preterm Infants
50%
PIVKA-II
42%
Cardiovascular Disease
40%
Dephosphorylated Uncarboxylated Matrix Gla Protein
40%
COVID-19
35%
Matrix Gla Protein
35%
Vitamin K1
28%
Dp-ucMGP
28%
Elastic Fibers
21%
Hit Molecules
20%
Chronic Kidney Disease Patients
20%
Central Diastolic Blood Pressure
20%
Medicine and Dentistry
Matrix Gla Protein
73%
Blood Vessel Calcification
70%
Des-Gamma Carboxyprothrombin
66%
Cardiovascular System
50%
Acid Sphingomyelinase
50%
Chronic Kidney Disease
50%
Red Blood Cell Distribution Width
50%
Vitamin K Deficiency
50%
COVID-19
50%
Phylloquinone
50%
Vascular Smooth Muscle Cell
50%
Lymphocyte
50%
Neutrophil
50%
Haptocorrin
40%
Cardiovascular Disease
40%
Prothrombin
29%
Osteocalcin
25%
Elastic Fiber
25%
In Vitro
20%
Diastolic Blood Pressure
20%
C Reactive Protein
20%
Procoagulant
16%
Protein S
16%
Thromboembolism
16%
Desmosine
16%
Supplementation
12%
Prevalence
12%
Neonatal Infant
12%
Observational Study
12%
Infancy
12%
